Comments

Champions Oncology

CSBRNASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$5.05
0.00500.10%
At Close: -
$5.12
0.071.39%
After Hours: Jul 18, 6:23 PM EDT
15 minutes delayed
Q4 2024 Earnings were released on Thu Jul 18th, after the market close
The most recent conference call was at 16:30 PM, 4 days ago Click to view past webcast
Champions Oncology (CSBR) ForecastNewsEarnings

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

Champions Oncology (NASDAQ:CSBR) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Get Alert
07/21/2022CSBR
Champions Oncology
FY2023———$58.93M$58.93M$57.19MGet Alert
03/15/2022CSBR
Champions Oncology
FY2022———$47.20M$49.25M$48.29MGet Alert
12/14/2020CSBR
Champions Oncology
FY2021———$38.55M$40.15M$38.56MGet Alert

FAQ

Q

What is the most recent guidance for Champions Oncology (CSBR)?

A

There have been no specific sales or earnings guidance reported for Champions Oncology in recent months.

Browse guidance and forecast on all stocks.

People Also Watch